Investment analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Merus in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A.

CEO Haruo Naito highlighted a 9% year-on-year revenue increase to 601.2 billion yen, with a focus on the pharmaceutical business driving growth. Key contributors included LEQEMBI with a 28.1 billion ...

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

These three companies will soon be joined on European stockmarkets by Spanish travel technology company HBX Group. The book got covered on Friday and HBX is expected to price at €11.50 a share, the ...

RECAP: Asian equities paused yesterday after a week of decent gains led by the return of risk-on sentiment in China, especially among technology storks, but tariff worries continue to hang over the ...

The US CPI and retail sales reports will be the main economic data releases next week, Deutsche Bank Research said in a report today. The focus will also be on Federal Reserve Chairman Jerome Powell's ...

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...

Nike’s ( NYSE: NKE) turnaround plan will take even longer than anticipated as management acknowledged the competitive threat ...

At this time, I would like to welcome everyone to Ford of Corporation's 4th quarter 2024 earnings results conference call. (Operator Instructions) I would now like to turn the call over to Ms. Elena ...

Thank you for attending today's Pinterest Inc. fourth-quarter and full-year 2024 earnings call. (Operator Instructions) I'll now hand the call over to Andrew Somberg, Vice President of Investor ...